Our Q3 earnings report is now available, showcasing strong global growth and our continued commitment to patient care. Read more about our results and impact at: <a href="https://t.co/sZfD6c6vIp&quot; target="_blank">https://t.co/sZfD6c6vIp</a&gt;

<a href="https://twitter.com/hashtag/FinancialResults?src=hashtag_click&quot; target="_blank">#FinancialResults</a> <a href="https://twitter.com/hashtag/Earnings?src=hashtag_click&quot; target="_blank">#Earnings</a>

Our Q3 earnings report is now available, showcasing strong global growth and our continued commitment to patient care. Read more about our results and impact at: <a href="https://okt.to/PXHtg4&quot; target="_blank">https://okt.to/PXHtg4</a&gt;

<a href='https://www.linkedin.com/feed/hashtag/?keywords=FinancialResults&highli…; target='_blank'>#FinancialResults</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Earnings&highlightedUpd…; target='_blank'>#Earnings</a>

Left untreated, Afib can raise stroke risk up to 5x. It’s important to listen to the warning signs of your body and check in with your doctor to make sure you’re on the right treatment plan.​ <a href="https://www.facebook.com/hashtag/WorldStrokeDay&quot; target="_blank">#WorldStrokeDay</a> <a href="https://www.facebook.com/hashtag/StrokeAwareness&quot; target="_blank">#StrokeAwareness</a> <a href="https://www.facebook.com/hashtag/Afib&quot; target="_blank">#Afib</a>

We’re proud to share that AtriCure has once again been certified as a Great Place To Work in the Netherlands, United Kingdom and Australia! This recognition reflects the feedback and experiences of our incredible employees who help make AtriCure a great place to work around the world. <a href='https://www.linkedin.com/feed/hashtag/?keywords=GreatPlacetoWork&highli…; target='_blank'>#GreatPlacetoWork</a>

We’re proud to share that AtriCure has once again been certified as a Great Place To Work in the Netherlands, United Kingdom and Australia! This recognition reflects the feedback and experiences of our incredible employees who help make AtriCure a great place to work around the world. <a href="https://www.facebook.com/hashtag/GreatPlacetoWork&quot; target="_blank">#GreatPlacetoWork</a>

Post-amputation patients often suffer from post-surgical pain. With the new cryoXT™ probe, surgeons can now provide their patients with a non-opioid option to provide a more comfortable recovery experience.​

Find all the details here: <a href="https://t.co/T5yRbifPNE&quot; target="_blank">https://t.co/T5yRbifPNE</a&gt;

Post-amputation patients often suffer from post-surgical pain. With the new cryoXT™ probe, surgeons can now provide their patients with a non-opioid option to provide a more comfortable recovery experience.​

Find all the details here: <a href="https://okt.to/JKoYzy&quot; target="_blank">https://okt.to/JKoYzy</a&gt;

The BoxX-NoAF clinical trial will set out to evaluate the safety and effectiveness of cardiac ablation and LAAE during cardiac surgery for the prevention of new-onset Afib in cardiac surgery patients with risk factors, but no history of Afib.

For more trial details, visit:

Rhythm control through surgical ablation isn’t just about rhythm — it’s about preventing heart failure and improving long-term outcomes. ​​

Survivability increases when rhythm is restored.

Rhythm control through surgical ablation isn’t just about rhythm — it’s about preventing heart failure and improving long-term outcomes. ​​

Survivability increases when rhythm is restored.​​

It's time to stop overlooking surgical ablation. Patients can’t afford it.​​

Learn more about the benefit of restoring sinus rhythm: <a href="https://okt.to/Db6zVq&quot; target="_blank">https://okt.to/Db6zVq</a&gt;